Cargando…

Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer

Preoperative chemoradiotherapy (pre-CRT) has been represented as the standard treatment for locally advanced rectal cancer (LARC), but large variations of tumor radiation response to CRT have been reported in the clinic. To explore the function of microRNAs as potential therapeutic predictors of pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Jing, Li, Ning, Wang, Xin, Ren, Hua, Wang, Weihu, Wang, Shulian, Song, Yongwen, Liu, Yueping, Li, Yexiong, Zhou, Xuantong, Luo, Aiping, Liu, Zhihua, Jin, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325438/ https://www.ncbi.nlm.nih.gov/pubmed/27572313 http://dx.doi.org/10.18632/oncotarget.11649

Ejemplares similares

Genetic polymorphisms in genes regulating cell death and prognosis of patients with rectal cancer receiving postoperative chemoradiotherapy
por: Chen, Hongxia, et al.
Publicado: (2023)

Inter‐ and intrafractional setup errors and baseline shifts of fiducial markers in patients with liver tumors receiving free‐breathing postoperative radiation analyzed by cone‐beam computed tomography
por: Zhang, Tao, et al.
Publicado: (2014)

Associations of Genetic Variations in Mismatch Repair Genes MSH3 and PMS1 with Acute Adverse Events and Survival in Patients with Rectal Cancer Receiving Postoperative Chemoradiotherapy
por: Yang, Jie, et al.
Publicado: (2019)

Postoperative intensity-modulated radiation therapy provides favorable local control and low toxicities in patients with soft tissue sarcomas in the extremities and trunk wall
por: Wang, Jianyang, et al.
Publicado: (2015)

Prospective evaluation of microscopic extension using whole-mount preparation in patients with hepatocellular carcinoma: Definition of clinical target volume for radiotherapy
por: Wang, Weihu, et al.
Publicado: (2010)

Down-staging depth score could be a survival predictor for locally advanced gastric cancer patients after preoperative chemoradiotherapy
por: Li, Ning, et al.
Publicado: (2021)

Genome landscapes of rectal cancer before and after preoperative chemoradiotherapy
por: Yang, Jie, et al.
Publicado: (2019)

A Phase II prospective nonrandomized trial of magnetic resonance imaging-guided hematopoietic bone marrow-sparing radiotherapy for gastric cancer patients with concurrent chemotherapy
por: Wang, Jianyang, et al.
Publicado: (2016)

Development and Validation of an MRI-Based Nomogram Model for Predicting Disease-Free Survival in Locally Advanced Rectal Cancer Treated With Neoadjuvant Radiotherapy
por: Chen, Silin, et al.
Publicado: (2021)

Adjuvant Chemoradiotherapy Versus Adjuvant Chemotherapy for Stage III Gastric or Gastroesophageal Junction Cancer After D2/R0 Resection
por: Shi, Jinming, et al.
Publicado: (2022)

Comparison of outcome and toxicity of postoperative intensity‐modulated radiation therapy with two‐dimensional radiotherapy in patients with soft tissue sarcoma of extremities and trunk
por: Wang, Jianyang, et al.
Publicado: (2019)

Response prediction and risk stratification of patients with rectal cancer after neoadjuvant therapy through an analysis of circulating tumour DNA
por: Liu, Wenyang, et al.
Publicado: (2022)

Risk stratification for prediction of locoregional recurrence in patients with pathologic T1–2N0 breast cancer after mastectomy
por: Wang, Jianyang, et al.
Publicado: (2020)

Preoperative T and N Restaging of Rectal Cancer After Neoadjuvant Chemoradiotherapy: An Accuracy Comparison Between MSCT and MRI
por: Liu, Wenjuan, et al.
Publicado: (2022)

Efficacy of hypofractionated preoperative chemoradiotherapy in rectal cancer
por: Cho, Ick Joon, et al.
Publicado: (2023)

Preoperative versus postoperative chemo-radiotherapy for locally advanced gastric cancer: a multicenter propensity score-matched analysis
por: Li, Ning, et al.
Publicado: (2022)

Assessment and validation of the internal gross tumour volume of gastroesophageal junction cancer during simultaneous integrated boost radiotherapy
por: Shi, Jinming, et al.
Publicado: (2022)

Effectiveness of the AJCC 8th edition staging system for selecting patients with T1–2N1 breast cancer for post-mastectomy radiotherapy: a joint analysis of 1986 patients from two institutions
por: Wang, Shulian, et al.
Publicado: (2020)

A review of preoperative chemoradiotherapy for lower rectal cancer
por: Beppu, Naohito, et al.
Publicado: (2018)

Long-term outcomes of moderately hypofractionated radiotherapy (67.5 Gy in 25 fractions) for prostate cancer confined to the pelvis: a single center retrospective analysis
por: Yao, Lihong, et al.
Publicado: (2020)

A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancer
por: Li, Ning, et al.
Publicado: (2018)

Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
por: Li, Anchuan, et al.
Publicado: (2022)

Knowledge, Attitudes, and Practices Related to Preoperative Chemoradiotherapy in Rectal Cancer Patients
por: Chen, Xingxing, et al.
Publicado: (2016)

Preoperative Chemoradiotherapy in Elderly Patients with Locally Advanced Rectal Cancer
por: De Felice, Francesca, et al.
Publicado: (2013)

Effect of preoperative chemoradiotherapy on the immunological status of rectal cancer patients
por: Yasui, Kazuaki, et al.
Publicado: (2020)

Organ preservation for early rectal cancer using preoperative chemoradiotherapy
por: Son, Gyung Mo
Publicado: (2023)

Upregulated MUC2 Is an Unfavorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative CCRT
por: Chou, Chia-Lin, et al.
Publicado: (2021)

Superoxide Dismutase Mimic, MnTE-2-PyP Enhances Rectal Anastomotic Strength in Rats after Preoperative Chemoradiotherapy
por: Yang, Yu, et al.
Publicado: (2020)

Systematic review and meta-analysis of preoperative chemoradiotherapy with or without oxaliplatin in locally advanced rectal cancer
por: Zheng, Jiabin, et al.
Publicado: (2017)

Translational Potential of MicroRNAs for Preoperative Staging and Prediction of Chemoradiotherapy Response in Rectal Cancer
por: Machackova, Tana, et al.
Publicado: (2019)

Biomarkers of Favorable vs. Unfavorable Responses in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy
por: Lee, Hsin-Hua, et al.
Publicado: (2022)

MRI-based radiomics to predict neoadjuvant chemoradiotherapy outcomes in locally advanced rectal cancer: A multicenter study
por: Xiang, Yirong, et al.
Publicado: (2022)

Clinical Significance of Tumor Regression Grade in Rectal Cancer with Preoperative Chemoradiotherapy
por: Park, Young Joo, et al.
Publicado: (2010)

The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer
por: Scabini, Stefano, et al.
Publicado: (2013)

Surgical issues in locally advanced rectal cancer treated by preoperative chemoradiotherapy
por: Lim, Seok-Byung, et al.
Publicado: (2013)

Predicting multi-class responses to preoperative chemoradiotherapy in rectal cancer patients
por: Gim, Jungsoo, et al.
Publicado: (2016)

Beware of Early Relapse in Rectal Cancer Patients Treated With Preoperative Chemoradiotherapy
por: Oh, Seul Gi, et al.
Publicado: (2020)

Analysis of influencing factors of no/low response to preoperative concurrent chemoradiotherapy in locally advanced rectal cancer
por: Wu, Fengpeng, et al.
Publicado: (2020)

PCSK1 Overexpression in Rectal Cancer Correlates with Poor Response to Preoperative Chemoradiotherapy and Prognosis
por: Chou, Chia-Lin, et al.
Publicado: (2020)

Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy
por: Truelsen, Christina Glismand, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k3o3q6104htr50276bmg9o0nk0